The focus of my research has been the investigation of the mechanism(s) regulating metabolic networks to gain a comprehensive understanding of cellular metabolism in normal and disease states. A special emphasis is on development of a novel pharmacotherapeutic intervention to mitigate metabolic derangements of diverse origin, including defects of the urea cycle and ammonia detoxification, fatty acid oxidation and/or Metabolic Syndromes. In addition, I am collaborating in the investigation of ketogenic diet in cases of neurochemical aberrations to develop treatments for inherited metabolic disease, hypoxia, cerebral palsy, and epilepy. Also, I am participating in studying the beneficial action of branched chain amino acids following neurological dysfunction caused by traumatic brain injury (TBI), and in the investigation of metabolic alteration that occurring in cancer patients prior and/or following treatment. Unique feature of my research is the use of in vivo, organ perfusion, isolated mitochondria or isolated cells as model systems, combined with the use of molecular biology, 15N or 13C as metabolic tracer and Nuclear Magnetic Resonance and/or Mass Spectrometry techniques with which to monitor metabolic fluxes and intermediates in order to pinpoint metabolic defect(s), and determining the coupling between metabolic profiling and genes expression in normal and disease states.
Selected Publications
Kasumov T., Comte B, Puchowicz M. A., Brunengraber L., Jobbins K., Thomas K., Puchowicz MA, David F., Kinman P., Wherli S., Dahms W., Kerr D., Nissim I., Brunengraber H.: New secondary metabolites of phenylbutyrate in humans and rat. Drug Met. & Disposition 32: 1-10, 2004.
Welbourne T, and Nissim I: Acidosis and amino acid metabolism Metabolic & Therapeutic Aspect of Amino Acids in Clinical Nutrition, 2nd edition. Luc A (eds.). CRC Press, Page: 375-388, 2004.
Yudkoff M, Daikhin Y, Nissim I, Horyn O, Lazarow A, Nissim I: Metabolism of brain amino acids following pentylenetetrazole treatment. Epilepsy Res 53(1-2): 151-162, 2003.
Welbourne TC, Friday E, Fowler R, Turturro F, Nissim I: Troglitazone acts by PPAR{gamma} and PPAR{gamma}-independent pathways on LLC-PK1-F+ acid-base metabolism. Am J Physiol Renal Physiol September 2003 Notes: Epub ahead of print.
Nissim I, Horyn O, Luhovyy B, Lazarow A, Daikhin Y, Nissim I, Yudkoff M.: Role of the glutamate dehydrogenase reaction in furnishing aspartate nitrogen for urea synthesis: studies in perfused rat liver with 15N. Biochem J 376: 179-188, 2003.
Comte B, Kasumov T, Pierce BA, Puchowicz MA, Scott ME, Dahms W, Kerr D, Nissim I, Brunengraber H.: Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humans. J Mass Spectrom 37(6): 581-590, 2002.
Brosnan JT, Brosnan ME, Nissim I: Application of 15N to the study of hepatic nitrogen metabolism. Adv Enzyme Regul 42: 305-315, 2002.
Coates G, Nissim I, Battarbee H, Welbourne T: Glitazones regulate glutamine metabolism by inducing a cellular acidosis in MDCK cells. Am J Physiol Endocrinol Metab 283(4): E729-E737, 2002.
Nissim I, Horyn O, Daikhin Y, Nissim I, Lazarow A, Yudkoff M: Regulation of urea synthesis by agmatine in the perfused liver: studies with 15N. Am J Physiol Endocrinol Metab 283(6): E1123-E1134, 2002.
Feldkamp T, Kribben A, Nissim I, Weinberg J.M, M.A. Venkatschalam: Dependence of proximal tubule (PT) energetics on mitochondrial complex I and its relation to energetic failure after hypoxia/reoxygenation (H/R). J AM SOC NEPHROL 13(Suppl. S): 321A, September 2002.
back to top
Last updated: 07/10/2012
The Trustees of the University of Pennsylvania